ADVERTISEMENT
Pharma Q4 – Higher Profitability With Easing Price Erosion, New Launches, Lower Cost Prices: Axis Securities
High single-digit domestic growth is expected in FY25E
10 Jun 2024, 11:59 AM IST ![NDTV Profit](/icons/feather-without-circle.svg)
![NDTV Profit](/icons/timer.svg)
![<div class="paragraphs"><p>Colourful capsules arranged for photograph. (Source: pxhere.com)</p></div>](https://media.assettype.com/bloombergquint%2F2023-01%2Fee4a84eb-c674-48fd-8680-67a06dc7622e%2FColourful_capsules_arranged_for_photograph___Source_pxhere_com_.jpg?rect=0%2C240%2C3315%2C1865&auto=format%2Ccompress&w=200)
Colourful capsules arranged for photograph. (Source: pxhere.com)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
![](/images/white_gradient.png)
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
Access to
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Lite
Experience
Members-Only
Rewards
NDTV Profit
Exclusive Stories
Full Access to
NDTV Profit App
Access to
20,000+
Research Reports
Ad-Lite
Experience
NDTV Profit
Exclusive Stories
Curated
Newsletters
Priority Pass
to Special Events
Members-Only
Rewards
Full Access to
NDTV Profit App
Still Not convinced ? Know More
ADVERTISEMENT